CHSH, working with the Hemmelrath Partnerschaftsgesellschaft, has advised Immundiagnostik AG, a German laboratory diagnostics company headquartered in Bens-heim, on its acquisition of Austrian start-up Kiweno. Kiweno was advised by 42Law.
The transaction, which closed in June 2019, was an asset deal. The new KI-WENO GmbH, wholly-owned by Immundiagnostik, acquired the entire laboratory diagnostics business of the Austrian start-up. Kiweno will continue operating from its current site in Tyrol.
Immundiagnostik specializes in the development and production of parameter and detection methods for laboratory diagnostics and medical research. Its focus lies on developing immunological detection methods.
The CHSH team consisted of Partners Heinrich Foglar-Deinhardstein, Thomas Zivny, and Mark Krenn, Attorneys Christopher Peitsch, Katharina Majchrzak, Franziska Paefgen, and Jakob Hartig, and Associates Katharina Wilding and Rea Psorn.
The Hemmelrath Partnerschaftsgesellschaft team was led by Partner Barbara von Horstig.
The 42Law team was led by Partner Christof Strasser.
